(MENAFN- PR Newswire) NEW YORK, June 7, 2023 /PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
VectivBio Holding AG (NASDAQ: vect )'s
sale to
Ironwood Pharmaceuticals, Inc. for $17.00 per share.
If you are a VectivBio shareholder, click here to learn more about your rights and options .
National Instruments Corporation (NASDAQ: nati )'s
sale to
Emerson Electric Co. for $60.00 per share in cash. If you are a National Instruments shareholder, click here to learn more about your rights and options .
CTI BioPharma Corp. (NASDAQ: ctic )'s
sale to Swedish Orphan Biovitrum AB for $9.10 per share.
If you are a CTI BioPharma shareholder, click here to learn more about your rights and options .
U.S. Xpress Enterprises, Inc. (NYSE: usx )'s
sale to Knight-Swift Transportation Holdings Inc. for $6.15 per share in cash. If you are a U.S. Xpress shareholder, click here to learn more about your rights and options .
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected]
or [email protected] .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
SOURCE Halper Sadeh LLP
MENAFN07062023003732001241ID1106407614
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.